BioKier
Latest round
- Series A
Last raised
- Jul 2013
Total raised
- $1.7M
Investors
- 2
About BioKier
BioKier, Inc.BioKier, Inc. is dedicated to the development of products aimed at enhancing metabolic control for diabetes management. Founded by Roger Nolan, the company is headquartered in Chapel Hill, US.15 mn on July 30, 2014.BioKier, Inc. specializes in the development of innovative oral products aimed at managing lipid and glucose levels in patients, particularly those with type 2 diabetes and insulin resistance. The company’s primary offerings replicate the metabolic effects of bariatric surgery, an established treatment known for its effectiveness in resolving diabetes and enhancing cardiometabolic health. BioKier's flagship products include BKR-017 and BKR-013, utilizing colon-targeted nutrient delivery mechanisms to improve gut hormone secretion and regulation of glucose and lipids. These products are currently undergoing clinical trials and have shown promising results.BioKier's revenue model principally centers around partnerships and clinical trial collaborations within the healthcare and pharmaceutical sectors. The company facilitates direct-to-consumer transactions through healthcare providers who prescribe its products for diabetes management, especially as they near commercialization. While specific pricing structures for their products remain undisclosed, BioKier’s offerings are positioned competitively in the diabetes management market.BioKier, Inc. The company is actively seeking to expand its market presence in North America and Europe, targeting additional healthcare providers and diabetes management programs by the end of 2024. These strategic initiatives will position BioKier for future growth and enhanced market penetration.
Who invested in BioKier
2 investors across 1 round
See all investors in BioKier
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 24, 2013
Amount
$1.7M
Investors
Questions about BioKier
Who invested in BioKier?
BioKier has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioKier raised?
BioKier has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioKier last raise money?
BioKier's most recent round on record is a Series A, in Jul 2013.
What does BioKier do?
BioKier is a pharmaceuticals company.
Where is BioKier headquartered?
BioKier is headquartered in Chapel Hill, US.
Which VCs invest in companies like BioKier?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BioKier's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BioKier? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.